Bridgeway Capital Management, LLC Sqz Biotechnologies CO Transaction History

Bridgeway Capital Management, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$2.16 - $3.48 $54,000 - $87,000	25,000 Added 61.27%	65,800 $150,000
Q2 2022 Aug 15, 2022	BUY	$2.77 - $5.0 $34,348 - $62,000	12,400 Added 43.66%	40,800 $130,000
Q1 2022 May 16, 2022	BUY	$4.01 - $10.42 $113,884 - $295,928	28,400 New	28,400 $137,000

1.47M

Ticker SQZ
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,248,600
Market Cap $1.46M
Description
SQZ Biotechnologies Company, a clinical-stage biotechnology company, develops cell therapies for patients with cancer, autoimmune, infectious diseases, and other serious conditions. Its lead product candidate is SQZ-PBMC-HPV, from its SQZ Antigen Presenting Cells platform, which is in a Phase I clinical trial as a monotherapy and in combination ...

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridgeway Capital Management, LLC with notifications on news.